Medulloblastoma, from the CureRays guide library.

Medulloblastoma is a fast-growing brain tumor of the cerebellum, most common in children; it is highly curable with surgery, craniospinal radiation, and chemotherapy, and modern radiation is carefully shaped to protect the developing brain.

What it is.

Medulloblastoma is a type of brain tumor that begins in the cerebellum, the part of the brain at the back of the head that controls balance and coordination. It is the most common cancerous brain tumor in children, though it can occasionally occur in adults. Because it sits near the fluid-filled spaces of the brain, medulloblastoma can block the normal flow of cerebrospinal fluid, causing pressure to build up — leading to headaches (often worse in the morning), nausea and vomiting, and problems with balance and walking. A defining feature is that medulloblastoma can spread through the cerebrospinal fluid to coat the surface of the brain and the spinal cord, which is why treatment must address the entire brain and spine, not just the original tumor. Doctors now recognize that medulloblastoma is not one disease but several molecular subgroups, each with a different biology and outlook, and this knowledge increasingly guides how intensively each child is treated. Despite being aggressive, medulloblastoma is one of the more curable brain tumors, especially when caught and treated promptly. Treatment is a coordinated effort: surgery to remove as much tumor as safely possible, radiation to the whole brain and spine plus a focused boost to the tumor area, and chemotherapy. Because most patients are children whose brains and bodies are still developing, a central goal is to cure the cancer while protecting long-term thinking, growth, and quality of life.

How radiation treats it.

Radiation therapy uses focused high-energy beams to damage the DNA inside cancer cells so they can no longer grow and divide. Medulloblastoma is especially sensitive to radiation, which is one reason it is so curable, but treating it well requires addressing a particular challenge: the tumor can shed cells into the cerebrospinal fluid that bathes the brain and spinal cord, so those cells can travel and settle far from where the tumor started. For this reason the standard radiation approach is craniospinal irradiation — treating the entire brain and spinal cord at a lower dose to destroy any wandering cells — followed by a focused higher-dose boost to the original tumor site. Because most patients are children whose brains, spines, hearts, and bodies are still developing, protecting healthy tissue is just as important as treating the cancer. Modern planning with intensity-modulated radiation and, where available, proton therapy makes this possible. Protons are particularly valuable here: a proton beam deposits its energy and then stops, so when the spine is treated the radiation does not continue forward into the heart, lungs, and abdomen, and when the tumor area is boosted, nearby healthy brain is spared. For average-risk patients, combining radiation with chemotherapy has allowed doctors to lower the radiation dose to the whole brain and spine while keeping cure rates high — an important advance for reducing effects on learning, growth, and hormones. In the youngest children, teams may delay or limit radiation, leaning on chemotherapy first. Your child's radiation oncologist designs the plan to cure the cancer while protecting long-term development as much as possible.

The ways we can treat it.

Craniospinal irradiation (CSI). Radiation is delivered to the entire brain and spinal cord to destroy tumor cells that may have spread through the cerebrospinal fluid, the foundation of curative treatment for most patients.

Tumor-bed boost (IMRT or focused beams). After whole brain-and-spine treatment, a higher dose is focused precisely on the area where the tumor was, sparing surrounding healthy brain.

Proton therapy. Proton beams stop at a controlled depth, so when treating the spine the dose does not pass through to the heart, lungs, and abdomen, and when boosting the tumor it spares nearby brain — especially valuable in growing children.

Reduced-dose radiation in favorable cases. For average-risk and certain favorable-biology tumors, a lower craniospinal dose combined with chemotherapy maintains high cure rates while lessening long-term effects on the developing brain.

Questions we hear often.

Why does radiation treat the whole brain and spine, not just the tumor? Medulloblastoma can release cells into the cerebrospinal fluid that flows around the brain and spinal cord, so those cells can travel and settle elsewhere. Treating the entire brain and spine destroys any hidden cells, and then a focused boost adds extra dose to where the tumor began. This combination is what makes the cancer so curable.

Is proton therapy better for children with medulloblastoma? Protons can deliver the needed dose to the brain and spine while stopping before they reach the heart, lungs, and abdominal organs, which spares developing tissue and tends to reduce long-term side effects. It is especially valued in children, though tumor control is excellent with both proton and modern conventional radiation.

Can treatment be made gentler for favorable tumors? Yes. For average-risk and favorable-biology tumors, combining a lower craniospinal radiation dose with chemotherapy keeps cure rates high while lessening effects on learning and growth. Doctors increasingly use the tumor's molecular subgroup to decide how much treatment is needed.

This guide is informational only. It is not medical advice — please confirm anything here with your care team.